Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells

Nature

Volumn 441, Issue 7090, 2006, Pages 235-238

  Bettelli, Estelle ^a   Carrier, Yijun ^a   Gao, Wenda ^b   Korn, Thomas ^a   Strom, Terry B ^b   Oukka, Mohamed ^c   Weiner, Howard L ^a   Kuchroo, Vijay K ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMEDICAL ENGINEERING; CYTOLOGY; GROWTH KINETICS; IMMUNOLOGY; PROTEINS; TISSUE;

ACUTE PHASE PROTEIN; AUTOIMMUNE TISSUE INJURY; INTRACELLULAR PATHOGENS; PATHOGENIC EFFECTOR;

CELLS;

INTERLEUKIN 17; INTERLEUKIN 23; INTERLEUKIN 6; TRANSFORMING GROWTH FACTOR BETA;

DEVELOPMENTAL STAGE; IMMUNITY; PATHOGEN; PROTEIN;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNITY; CD4+ CD25+ FOXP3+ T LYMPHOCYTE; CD4+ CD25+ T LYMPHOCYTE; CONTROLLED STUDY; FOXP3+ T LYMPHOCYTE; GENE LOCUS; HELPER CELL; INFLAMMATION; LYMPHOCYTE ACTIVATION; LYMPHOCYTE DIFFERENTIATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; TH1 CELL; TH17 CELL; TH2 CELL; TISSUE INJURY; TRANSGENIC MOUSE;

ANIMALS; ANTIGENS, CD4; AUTOIMMUNITY; CELL DIFFERENTIATION; CENTRAL NERVOUS SYSTEM; CYTOKINES; FORKHEAD TRANSCRIPTION FACTORS; INTERLEUKIN-17; INTERLEUKIN-6; MICE; RECEPTORS, INTERLEUKIN-2; TH1 CELLS; TH2 CELLS; TRANSFORMING GROWTH FACTOR BETA;

ANIMALIA; MUS MUSCULUS;

EID: 33646577466     PISSN: 00280836     EISSN: 14764679     Source Type: Journal    
DOI: 10.1038/nature04753     Document Type: Article

References (23)

1. H2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7, 145-173 (1989).
2. + T lymphocytes. Immunol. Today 9, 268-274 (1988).
3. Langrish, C. L. et al. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J. Exp. Med. 201, 233-240 (2005).
4. + effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nature Immunol. 6, 1123-1132 (2005).
5. Park, H. et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nature Immunol. 6, 1133-1141 (2005).
6. + regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annu. Rev. Immunol. 22, 531-562 (2004).
7. + regulatory T cells by TGF-β induction of transcription factor Foxp3. J. Exp. Med. 198, 1875-1886 (2003).
8. Hirano, T. Interleukin 6 and its receptor: ten years later. Int. Rev. Immunol. 16, 249-284 (1998).
9. Ozato, K., Tsujimura, H. & Tamura, T. Toll-like receptor signaling and regulation of cytokine gene expression in the immune system. Biotechniques 33 (Suppl.), S66-S68 (2002).
10. Hori, S., Nomura, T. & Sakaguchi, S. Control of regulatory T cell development by the transcription factor Foxp3. Science 299, 1057-1061 (2003).
11. + regulatory T cells. Nature Immunol. 4, 330-336 (2003).
12. + T regulatory cells. Nature Immunol. 4, 337-342 (2003).
13. Bettelli, E. et al. Myelin oligodendrocyte glycoprotein-specific T cell receptor transgenic mice develop spontaneous autoimmune optic neuritis. J. Exp. Med. 197, 1073-1081 (2003).
14. Aggarwal, S., Ghilardi, N., Xie, M. H., de Sauvage, F. J. & Gurney, A. L. Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17. J. Biol. Chem. 278, 1910-1914 (2003).
15. Parham, C. et al. A receptor for the heterodimeric cytokine IL-23 is composed of IL-12Rβ1 and a novel cytokine receptor subunit, IL-23R. J. Immunol. 168, 5699-5708 (2002).
16. Veldhoen, M., Hocking, R. J., Atkins, C. J., Locksley, R. M. & Stockinger, B. TGFβ in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 24, 179-189 (2006).
17. Gorelik, L. & Flavell, R. A. Transforming growth factor-β in T-cell biology. Nature Rev. Immunol. 2, 46-53 (2002).
18. Shull, M. M. et al. Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory disease. Nature 359, 693-699 (1992).
19. + T cells with prevention of severe destructive arthritis in Borrelia burgdorferi-vaccinated and challenged gamma interferon-deficient mice treated with anti-interleukin-17 antibody. Clin. Diagn. Lab. Immunol. 11, 1075-1084 (2004).
20. Samoilova, E. B., Horton, J. L., Hilliard, B., Liu, T. S. & Chen, Y. IL-6-deficient mice are resistant to experimental autoimmune encephalomyelitis: roles of IL-6 in the activation and differentiation of autoreactive T cells. J. Immunol. 161, 6480-6486 (1998).
21. Okuda, Y. et al. IL-6 plays a crucial role in the induction phase of myelin oligodendrocyte glucoprotein 35-55 induced experimental autoimmune encephalomyelitis. J. Neuroimmunol. 101, 188-196 (1999).
22. Okuda, Y., Sakoda, S., Saeki, Y., Kishimoto, T. & Yanagihara, T. Enhancement of Th2 response in IL-6-deficient mice immunized with myelin oligodendrocyte glycoprotein. J. Neuroimmunol. 105, 120-123 (2000).
23. Eugster, H. P. et al. Superantigen overcomes resistance of IL-6-deficient mice towards MOG-induced EAE by a TNFR1 controlled pathway. Eur. J. Immunol. 31, 2302-2312 (2001).